Vertex Pharmaceuticals (MA) Hepatitis C Drug, Telaprevir Achieves 75% Cure Rate in Study

Reuters -- A hepatitis C treatment being developed by Vertex Pharmaceuticals Inc led to a 75 percent cure rate in a pivotal trial of previously untreated patients, the company said on Tuesday.

Back to news